Ji Yoon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ji Yoon Kim has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Ho Yun Chung
Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
6 shared publications - Jongmin Lee
Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
6 shared publications - Sang Yub Lee
Sungkyunkwan University School of Medicine
6 shared publications - Seok-Jong Lee
Department of Dermatology, School of Medicine Kyungpook National University Daegu South Korea
6 shared publications - Seung Huh
Division of Vascular and Endovascular Surgery, Department of Surgery, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea
6 shared publications - Jeong Yeop Ryu
Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
5 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Wiley in Pediatric Blood & Cancer
Lorlatinib‐Containing Therapy for MYCN ‐Amplified, ALK ‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report
Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN ‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia. Lorlatinib‐containing chemotherapy resulted in near‐complete resolution of leptomeningeal disease and full neurologic recovery. Although subsequent CNS recurrence was confirmed and ultimately prompted CSI, the initial response permitted its deferral for 11 months. This case highlights the potential of lorlatinib‐containing therapy to reduce CNS tumor burden and serve as a bridging strategy to CSI despite concurrent MYCN amplification.
- 29 October 2026
- Published by Wiley in Pediatric Blood & Cancer
Open AccessLorlatinib‐Containing Therapy for MYCN ‐Amplified, ALK ‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report
Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN ‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia. Lorlatinib‐containing chemotherapy resulted in near‐complete resolution of leptomeningeal disease and full neurologic recovery. Although subsequent CNS recurrence was confirmed and ultimately prompted CSI, the initial response permitted its deferral for 11 months. This case highlights the potential of lorlatinib‐containing therapy to reduce CNS tumor burden and serve as a bridging strategy to CSI despite concurrent MYCN amplification.
- Open Access
- 13 June 2026
- Published by Springer Nature in Blood Research
- Vol. 61 (1) , 32
Cross-cultural validation and reliability of the Korean version of the Haemophilia Activities List
Purpose To translate, culturally adapt, and evaluate the reliability and construct validity of the Korean version of the Haemophilia Activities List (HAL) in adult patients with hemophilia. Methods This cross-sectional validation study included adult patients with hemophilia A and B. The HAL was translated into Korean using a standardized forward–backward translation process according to international guidelines. The participants completed the Korean HAL, the EuroQol Five-Dimension Five-Level Questionnaire (EQ-5D-5L), and the Routine Assessment of Patient Index Data 3 (RAPID3) questionnaire. Internal consistency was assessed using Cronbach’s alpha, test–retest reliability was assessed using intraclass correlation coefficients (ICCs), and construct validity was assessed using Spearman’s correlation analysis. Results A total of 87 adult patients completed the questionnaire. The mean age was 37 years (range, 18–62 years), and most participants had severe hemophilia. The Korean HAL demonstrated high internal consistency, with a Cronbach’s alpha coefficient of 0.97 for the total score and domain-specific values ranging from 0.78 to 0.95. The test–retest reliability was excellent, with an overall ICC of 0.95. Construct validity was supported by strong correlations between the HAL and EQ-5D-5L overall scores (r = 0.78, p < 0.01) and strong correlations with RAPID3 physical function scores (r = -0.82, p < 0.01). Conclusions The Korean version of the HAL demonstrated excellent reliability and good construct validity in adult patients with hemophilia. These findings support the use of the Korean HAL as a reliable and culturally appropriate patient-reported outcome measure to assess functional limitations in clinical practice and research.
- 13 June 2026
- Published by Springer Nature in Blood Research
- Vol. 61 (1) , 32
Open AccessCross-cultural validation and reliability of the Korean version of the Haemophilia Activities List
Purpose To translate, culturally adapt, and evaluate the reliability and construct validity of the Korean version of the Haemophilia Activities List (HAL) in adult patients with hemophilia. Methods This cross-sectional validation study included adult patients with hemophilia A and B. The HAL was translated into Korean using a standardized forward–backward translation process according to international guidelines. The participants completed the Korean HAL, the EuroQol Five-Dimension Five-Level Questionnaire (EQ-5D-5L), and the Routine Assessment of Patient Index Data 3 (RAPID3) questionnaire. Internal consistency was assessed using Cronbach’s alpha, test–retest reliability was assessed using intraclass correlation coefficients (ICCs), and construct validity was assessed using Spearman’s correlation analysis. Results A total of 87 adult patients completed the questionnaire. The mean age was 37 years (range, 18–62 years), and most participants had severe hemophilia. The Korean HAL demonstrated high internal consistency, with a Cronbach’s alpha coefficient of 0.97 for the total score and domain-specific values ranging from 0.78 to 0.95. The test–retest reliability was excellent, with an overall ICC of 0.95. Construct validity was supported by strong correlations between the HAL and EQ-5D-5L overall scores (r = 0.78, p < 0.01) and strong correlations with RAPID3 physical function scores (r = -0.82, p < 0.01). Conclusions The Korean version of the HAL demonstrated excellent reliability and good construct validity in adult patients with hemophilia. These findings support the use of the Korean HAL as a reliable and culturally appropriate patient-reported outcome measure to assess functional limitations in clinical practice and research.
- Open Access
- 30 April 2026
- Published by The Korean Society of Pediatric Hematology-Oncology in Clinical Pediatric Hematology-Oncology
- Vol. 33 (1) , 13-21
Family Perspectives and Support Needs for Pediatric Hospice and Palliative Care in South Korea
Bu Kyung Park and Ji Yoon Kim. CPHO 2026;33:13-21. https://doi.org/10.15264/cpho.2026.33.1.13
- 30 April 2026
- Published by The Korean Society of Pediatric Hematology-Oncology in Clinical Pediatric Hematology-Oncology
- Vol. 33 (1) , 13-21
Open AccessFamily Perspectives and Support Needs for Pediatric Hospice and Palliative Care in South Korea
Bu Kyung Park and Ji Yoon Kim. CPHO 2026;33:13-21. https://doi.org/10.15264/cpho.2026.33.1.13
- Open Access
- 21 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (25) , e38616
Hemophagocytic lymphohistiocytosis associated with acute otitis media: A case report
Introduction: Hemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening syndrome for which early recognition and treatment are essential for improving outcomes. HLH is characterized by uncontrolled immune activation leading to fever, cytopenias, hepatosplenomegaly, coagulation abnormalities, and elevated typical markers. This condition can be genetic or secondary, with the latter often triggered by infections. Here, we present a unique case of HLH secondary to acute otitis media (AOM), a common ear infection. Patient concerns: We describe a 4-year-old boy who initially presented with a high fever and otalgia, later diagnosed with bilateral AOM. Despite antibiotic treatment, his condition deteriorated. Diagnosis: The patient fulfilled diagnostic criteria for HLH. Interventions: Aggressive treatment by using combination therapy with immunoglobulins, intravenous steroids (dexamethasone), cyclosporine, and etoposide was performed. Outcomes: After 1 month of treatment, improvement in the otologic symptoms was observed, and hematological findings gradually improved and normalized. Lessions: The link between AOM and HLH may be associated with inflammatory responses and immunological mechanisms, highlighting the importance of considering HLH in severe infection cases. This case emphasizes the need for prompt diagnosis and management, especially in secondary HLH scenarios, to improve patient outcomes. It is imperative to be aware of the potential correlation between these 2 conditions, and healthcare professionals should consider the likelihood of HLH.
- 21 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (25) , e38616
Open AccessHemophagocytic lymphohistiocytosis associated with acute otitis media: A case report
Introduction: Hemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening syndrome for which early recognition and treatment are essential for improving outcomes. HLH is characterized by uncontrolled immune activation leading to fever, cytopenias, hepatosplenomegaly, coagulation abnormalities, and elevated typical markers. This condition can be genetic or secondary, with the latter often triggered by infections. Here, we present a unique case of HLH secondary to acute otitis media (AOM), a common ear infection. Patient concerns: We describe a 4-year-old boy who initially presented with a high fever and otalgia, later diagnosed with bilateral AOM. Despite antibiotic treatment, his condition deteriorated. Diagnosis: The patient fulfilled diagnostic criteria for HLH. Interventions: Aggressive treatment by using combination therapy with immunoglobulins, intravenous steroids (dexamethasone), cyclosporine, and etoposide was performed. Outcomes: After 1 month of treatment, improvement in the otologic symptoms was observed, and hematological findings gradually improved and normalized. Lessions: The link between AOM and HLH may be associated with inflammatory responses and immunological mechanisms, highlighting the importance of considering HLH in severe infection cases. This case emphasizes the need for prompt diagnosis and management, especially in secondary HLH scenarios, to improve patient outcomes. It is imperative to be aware of the potential correlation between these 2 conditions, and healthcare professionals should consider the likelihood of HLH.
- 7 February 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 703, 149565
Ibuprofen-induced multiorgan malformation during embryogenesis in Xenopus laevis (FETAX)
- 7 February 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 703, 149565
Ibuprofen-induced multiorgan malformation during embryogenesis in Xenopus laevis (FETAX)
- 10 January 2024
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 51 (5) , 353-359
The discriminative role of PROX‐1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion
Background: Venous malformations (VMs) are distinguished from lymphatic malformations (LMs) when specific diagnostic skin lesions are present. In the deep type, this is difficult by clinico‐radiologic evaluation alone. We aimed to investigate the usefulness of lymphatic vessel endothelial cell (LEC) markers for the differential diagnosis of the deep VMs and LMs.Methods: A retrospective study was conducted based on the medical records of patients with VMs and LMs who underwent biopsy with both D2‐40 and PROX‐1 immunohistochemistry. We compared the initial clinico‐radiological diagnosis with the final pathological diagnosis and identified which ones showed a difference.Results: From 261 patients who had VMs and LMs, 111 remained after the exclusion of those who showed definite surface diagnostic features. After pathological diagnosis with the expressions of D2‐40 and PROX‐1, 38 of 111 (34.2%) patients' final diagnoses were changed. Among these 38 cases, diagnosis was not changed by D2‐40 positivity alone, but changed by PROX‐1 positivity alone (52.6%) or by both (47.4%). The diagnostic changes were more frequent in the deep category (43.7%) than in the superficial category.Conclusions: Identifying the expression of D2‐40, and especially PROX‐1, in the differential diagnosis of VMs and LMs may provide important treatment guidelines and understanding their natural course.
- 10 January 2024
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 51 (5) , 353-359
The discriminative role of PROX‐1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion
Background: Venous malformations (VMs) are distinguished from lymphatic malformations (LMs) when specific diagnostic skin lesions are present. In the deep type, this is difficult by clinico‐radiologic evaluation alone. We aimed to investigate the usefulness of lymphatic vessel endothelial cell (LEC) markers for the differential diagnosis of the deep VMs and LMs.Methods: A retrospective study was conducted based on the medical records of patients with VMs and LMs who underwent biopsy with both D2‐40 and PROX‐1 immunohistochemistry. We compared the initial clinico‐radiological diagnosis with the final pathological diagnosis and identified which ones showed a difference.Results: From 261 patients who had VMs and LMs, 111 remained after the exclusion of those who showed definite surface diagnostic features. After pathological diagnosis with the expressions of D2‐40 and PROX‐1, 38 of 111 (34.2%) patients' final diagnoses were changed. Among these 38 cases, diagnosis was not changed by D2‐40 positivity alone, but changed by PROX‐1 positivity alone (52.6%) or by both (47.4%). The diagnostic changes were more frequent in the deep category (43.7%) than in the superficial category.Conclusions: Identifying the expression of D2‐40, and especially PROX‐1, in the differential diagnosis of VMs and LMs may provide important treatment guidelines and understanding their natural course.
- Open Access
- 15 January 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 686
Electrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
Acute lymphocytic leukemia is one of the most common cancers in children. Multi-drug chemotherapy is used for treatment, and the representative drug is vincristine. Although various side effects may occur due to vincristine, the association with peripheral neuropathy is high compared to that of other drugs. This study focused on children under the age of 18 years of age with ALL who received chemotherapy containing vincristine. We retrospectively analyzed the results of a nerve conduction study and a cumulative dose of vincristine in 30 children diagnosed with peripheral neuropathy. The average cumulative dose until diagnosis of vincristine-induced peripheral neuropathy was 14.99 ± 1.21 mg/m2, and motor nerves were predominantly involved. Additionally, a marked decrease in average amplitude was also observed in motor nerves. In addition, when the relationship between the incidence of peripheral neuropathy and the cumulative dose was analyzed through the survival curve, about 50% of children developed peripheral neuropathy at a dose of 15.5 ± 1.77 mg/m2. Based on the electrophysiological characteristics of pediatric vincristine-induced peripheral neuropathy, as well as the relationship between the incidence rate and the cumulative dose, it is possible to observe more closely the vincristine-induced peripheral neuropathy occurrence in children with ALL at an appropriate time.
- 15 January 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 686
Open AccessElectrophysiologic Patterns of Symptomatic Vincristine-Induced Peripheral Neuropathy in Children with Acute Lymphocytic Leukemia
Acute lymphocytic leukemia is one of the most common cancers in children. Multi-drug chemotherapy is used for treatment, and the representative drug is vincristine. Although various side effects may occur due to vincristine, the association with peripheral neuropathy is high compared to that of other drugs. This study focused on children under the age of 18 years of age with ALL who received chemotherapy containing vincristine. We retrospectively analyzed the results of a nerve conduction study and a cumulative dose of vincristine in 30 children diagnosed with peripheral neuropathy. The average cumulative dose until diagnosis of vincristine-induced peripheral neuropathy was 14.99 ± 1.21 mg/m2, and motor nerves were predominantly involved. Additionally, a marked decrease in average amplitude was also observed in motor nerves. In addition, when the relationship between the incidence of peripheral neuropathy and the cumulative dose was analyzed through the survival curve, about 50% of children developed peripheral neuropathy at a dose of 15.5 ± 1.77 mg/m2. Based on the electrophysiological characteristics of pediatric vincristine-induced peripheral neuropathy, as well as the relationship between the incidence rate and the cumulative dose, it is possible to observe more closely the vincristine-induced peripheral neuropathy occurrence in children with ALL at an appropriate time.
- 5 September 2022
- Published by Morressier GmbH
ESDR535 - A New Classification and Treatment Outcome of Hand Vitiligo: A Cluster Analysis
Vitiligo on the hands has a negative impact on daily lives of affected patients. However, hand lesions are usually considered to be resistant to | POSTER
- 5 September 2022
- Published by Morressier GmbH
ESDR535 - A New Classification and Treatment Outcome of Hand Vitiligo: A Cluster Analysis
Vitiligo on the hands has a negative impact on daily lives of affected patients. However, hand lesions are usually considered to be resistant to | POSTER
- Open Access
- 1 January 2022
- Published by Georg Thieme Verlag KG in Archives of Plastic Surgery
- Vol. 49 (01) , 115-120
Wall shear stress on vascular smooth muscle cells exerts angiogenic effects on extracranial arteriovenous malformations
Background In addition to vascular endothelial cells, vascular smooth muscle cells (VSMCs) are subject to continuous shear stress because of blood circulation. The angiogenic properties of VSMCs in extracranial arteriovenous malformations (AVMs) may exceed those of normal blood vessels if the body responds more sensitively to mechanical stimuli. This study was performed to investigate the hypothesis that rapid angiogenesis may be achieved by mechanical shear stress. Methods VSMCs were obtained from six patients who had AVMs and six normal controls. The target genes were set to angiopoietin-2 (AGP2), aquaporin-1 (AQP1), and transforming growth factor-beta receptor 1 (TGFBR1). Reverse-transcriptase polymerase chain reaction (RT-PCR) and real-time PCR were implemented to identify the expression levels for target genes. Immunofluorescence was also conducted. Results Under the shear stress condition, mean relative quantity values of AGP2, AQP1, and TGFBR1 in AVM tissues were 1.927±0.528, 1.291±0.031, and 2.284±1.461 when compared with neutral conditions. The expression levels of all three genes in AVMs were higher than those in normal tissue except for AQP1 under shear stress conditions. Immunofluorescence also revealed increased staining of shear stress-induced genes in the normal tissue and in AVM tissue. Conclusions Shear stress made the VSMCs of AVMs more sensitive. Although the pathogenesis of AVMs remains unclear, our study showed that biomechanical stimulation imposed by shear stress may aggravate angiogenesis in AVMs.
- 1 January 2022
- Published by Georg Thieme Verlag KG in Archives of Plastic Surgery
- Vol. 49 (01) , 115-120
Open AccessWall shear stress on vascular smooth muscle cells exerts angiogenic effects on extracranial arteriovenous malformations
Background In addition to vascular endothelial cells, vascular smooth muscle cells (VSMCs) are subject to continuous shear stress because of blood circulation. The angiogenic properties of VSMCs in extracranial arteriovenous malformations (AVMs) may exceed those of normal blood vessels if the body responds more sensitively to mechanical stimuli. This study was performed to investigate the hypothesis that rapid angiogenesis may be achieved by mechanical shear stress. Methods VSMCs were obtained from six patients who had AVMs and six normal controls. The target genes were set to angiopoietin-2 (AGP2), aquaporin-1 (AQP1), and transforming growth factor-beta receptor 1 (TGFBR1). Reverse-transcriptase polymerase chain reaction (RT-PCR) and real-time PCR were implemented to identify the expression levels for target genes. Immunofluorescence was also conducted. Results Under the shear stress condition, mean relative quantity values of AGP2, AQP1, and TGFBR1 in AVM tissues were 1.927±0.528, 1.291±0.031, and 2.284±1.461 when compared with neutral conditions. The expression levels of all three genes in AVMs were higher than those in normal tissue except for AQP1 under shear stress conditions. Immunofluorescence also revealed increased staining of shear stress-induced genes in the normal tissue and in AVM tissue. Conclusions Shear stress made the VSMCs of AVMs more sensitive. Although the pathogenesis of AVMs remains unclear, our study showed that biomechanical stimulation imposed by shear stress may aggravate angiogenesis in AVMs.
- Open Access
- 20 June 2021
- Published by Korean Cleft Palate-Craniofacial Association in Archives of Craniofacial Surgery
- Vol. 22 (3) , 141-147
Clinical assessment and management of auricular arteriovenous malformation: retrospective study
Arteriovenous malformation (AVM) which is a high-blood-flow lesion with connections between arteries and veins without an intervening capillary bed, is difficult to manage. The ear is the second most common site of extracranial AVM. However, studies regarding the management of this condition remain lacking. The purpose of this study was to share managing experiences in our center and to investigate the treatment effect through a retrospective analysis of cases. Among 265 patients with AVM treated in our vascular anomalies center between January 2008 and January 2021, 10 patients with auricular AVM were included in the study to investigate the lesion distribution, clinical stage, and treatment methods by performing a retrospective evaluation. Among 10 patients, five patients had AVMs distributed in the upper half of the ear, one patient in the lower half of the ear, and four patients in whole ear, respectively. Seven patients had Schobinger stage II, and three had stage III. One patient received surgical treatment only, four patients received sclerotherapy only, and five patients received both surgical treatment and sclerotherapy. The posttreatment status was checked as controlled in two patients, improved in seven patients, persistent in one patient. There were no worsening patients. Auricular AVM is a disease that is difficult to manage by one specific department, thus requiring a collaborative management effort from multidisciplinary team.
- 20 June 2021
- Published by Korean Cleft Palate-Craniofacial Association in Archives of Craniofacial Surgery
- Vol. 22 (3) , 141-147
Open AccessClinical assessment and management of auricular arteriovenous malformation: retrospective study
Arteriovenous malformation (AVM) which is a high-blood-flow lesion with connections between arteries and veins without an intervening capillary bed, is difficult to manage. The ear is the second most common site of extracranial AVM. However, studies regarding the management of this condition remain lacking. The purpose of this study was to share managing experiences in our center and to investigate the treatment effect through a retrospective analysis of cases. Among 265 patients with AVM treated in our vascular anomalies center between January 2008 and January 2021, 10 patients with auricular AVM were included in the study to investigate the lesion distribution, clinical stage, and treatment methods by performing a retrospective evaluation. Among 10 patients, five patients had AVMs distributed in the upper half of the ear, one patient in the lower half of the ear, and four patients in whole ear, respectively. Seven patients had Schobinger stage II, and three had stage III. One patient received surgical treatment only, four patients received sclerotherapy only, and five patients received both surgical treatment and sclerotherapy. The posttreatment status was checked as controlled in two patients, improved in seven patients, persistent in one patient. There were no worsening patients. Auricular AVM is a disease that is difficult to manage by one specific department, thus requiring a collaborative management effort from multidisciplinary team.